Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
出版年份 2013 全文链接
标题
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
作者
关键词
NSCLC, Patient-derived NSCLC xenograft, <em class=EmphasisTypeItalic >EGFR/KRAS</em> mutations, <em class=EmphasisTypeItalic >FGFR</em> 1 amplification
出版物
Journal of Translational Medicine
Volume 11, Issue 1, Pages 168
出版商
Springer Nature
发表日期
2013-07-11
DOI
10.1186/1479-5876-11-168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue
- (2013) Bumsoo Park et al. CANCER SCIENCE
- Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non-Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
- (2012) J. Zhang et al. CLINICAL CANCER RESEARCH
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Lung cancer: New biological insights and recent therapeutic advances
- (2011) Suresh S. Ramalingam et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
- (2011) Amit Dutt et al. PLoS One
- Vandetanib Improves Anti-Tumor Effects of L19mTNF in Xenograft Models of Esophageal Cancer
- (2010) M. Crescenzi et al. CLINICAL CANCER RESEARCH
- Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non-Small Cell Lung Cancer
- (2010) S. Hammer et al. CLINICAL CANCER RESEARCH
- Assessment of the In vivo Antitumor Effects of ENMD-2076, a Novel Multitargeted Kinase Inhibitor, against Primary and Cell Line-Derived Human Colorectal Cancer Xenograft Models
- (2010) J. J. Tentler et al. CLINICAL CANCER RESEARCH
- The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non-Small Cell Lung Cancer
- (2010) T. John et al. CLINICAL CANCER RESEARCH
- Advances in chemotherapy in advanced non-small-cell lung cancer
- (2010) Paolo Maione et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
- Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?☆
- (2009) Johannes Merk et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Recent advances of novel targeted therapy in non-small cell lung cancer
- (2009) Jed A Katzel et al. Journal of Hematology & Oncology
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
- (2008) I. Fichtner et al. CLINICAL CANCER RESEARCH
- METgene amplification orEGFRmutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors
- (2008) Takafumi Kubo et al. INTERNATIONAL JOURNAL OF CANCER
- BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
- (2008) D Li et al. ONCOGENE
- The use of xenograft models for the selection of cancer treatments with the EGFR as an example
- (2007) Teresa Troiani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started